Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year operating income growth rate
Latest
-43.55%
↑ 13% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-50.03%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -43.55% |
| 2023 | -19.21% |
| 2022 | -29.10% |
| 2021 | -96.38% |
| 2020 | -34.45% |
| 2019 | -127.57% |
| 2018 | 0.00% |